IMMURON LTD-SPON ADR (IMRN)
US45254U1016 - ADR
NMRC Reports Results for Campylobacter Controlled Human Infection Model Study
NMRC Reports Results for Campylobacter Controlled Human Infection Model Study
MELBOURNE, Australia, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), is an Australian based and globally integrated...
Immuron Plans Phase 2 Trial for IMM-529 following FDA review
Immuron Plans Phase 2 Trial for IMM-529 following FDA review
Key Points Immuron completes pre-IND meeting with FDA on the development of IMM-529 as product to specifically prevent or treat Clostridioides difficile...
Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®
Highlights: $3.5 (USD $2.3) million funding for NMRC and WRAIR approved by the U.S. Department of Defense to advance the development of...
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
MELBOURNE, Australia, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated...
Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect
Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect
MELBOURNE, Australia, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to invite shareholders to attend an investor...
Immuron announces record Travelan® sales globally, Australia and USA
Immuron requests pre-IND meeting for IMM-529 with FDA filing
Immuron requests pre-IND meeting for IMM-529 with FDA filing
MELBOURNE, Australia, July 02, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated...
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
MELBOURNE, Australia, June 05, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated...
Immuron CEO Steven Lydeamore to present at Peak Sky High
Immuron Board Changes
Immuron CEO Steven Lydeamore to present at Peak Sky High
MELBOURNE, Australia, May 31, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated...
Immuron Board Changes
MELBOURNE, Australia, May 31, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated...
Immuron Limited to Present at the Emerging Growth Conference
Immuron Limited to Present at the Emerging Growth Conference
MELBOURNE, Australia, May 07, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated...
Immuron Director Resignation
Immuron Director Resignation
MELBOURNE, Australia, May 03, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated...
Immuron to host Live Virtual Event
Immuron to host Live Virtual Event
MELBOURNE, Australia, April 15, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated...
Immuron Travelan® sales continued strong growth
Immuron Travelan® sales continued strong growth
Sales Highlights: Global FYTD Mar 2024 AUD$3.6 million up 154% on (prior comparative period) pcpMar 2024 Quarter AUD$1.3 million up 51%...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are worth checking out on Thursday to get an idea of the hottest stocks worth watching this morning!